NAPSA and squamous cell lung carcinoma: Specifically, we expected that the pathways selected by SLPR for the gene expression data would more effectively capture pathways associated with proteins known to be effective biomarkers for discrimination of lung adenocarcioma from lung squamous cell carcinoma (e.g. p63, TTF-1, CK 5/6 and Napsin-A ) (36–40).